DAX23.997 +0,3%ESt505.367 -0,1%Top 10 Crypto14,19 -0,4%Dow42.270 +0,1%Nas19.114 -0,3%Bitcoin91.736 ±0,0%Euro1,1349 ±0,0%Öl63,90 -0,4%Gold3.292 ±0,0%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
NVIDIA 918422 Rheinmetall 703000 RENK RENK73 Lufthansa 823212 HENSOLDT HAG000 BYD A0M4W9 Tesla A1CX3T Siemens Energy ENER6Y Mercedes-Benz Group (ex Daimler) 710000 thyssenkrupp 750000 Deutsche Telekom 555750 Infineon 623100 D-Wave Quantum A3DSV9 Amazon 906866 Apple 865985
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
US-Börsen schließen uneins -- DAX geht knapp unter 24.000er-Marke ins Wochenende -- VW in Gesprächen mit US-Regierung über Zölle -- Marvell Technology, D-Wave, Rheinmetall, Bitcoin im Fokus
Top News
KW 22: So haben Bitcoin, Ether & Co. in der vergangenen Woche performt KW 22: So haben Bitcoin, Ether & Co. in der vergangenen Woche performt
Neuzugang in den Top 3: So hat David Einhorns Greenlight Capital im ersten Quartal 2025 investiert Neuzugang in den Top 3: So hat David Einhorns Greenlight Capital im ersten Quartal 2025 investiert
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil
25 € Neukunden­bonus + 1 Aktie gratis. Hol Dir jetzt Dein finanzen.net ZERO-Depot!

Alkermes Aktie

Handeln
26,20 EUR -0,40 EUR -1,50 %
FSE
30,62 USD +0,36 USD +1,19 %
nachbörslich
BTT
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!
JETZT LOSLEGEN
Bei einem anderen Broker handelnSmartphone

Marktkap.4,40 Mrd. EUR

KGV13,26Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKNA1JKVH

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINIE00B56GVS15

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolALKS

Alkermes Aktien News

DatumMeistgelesen
PR NewswireAlkermes to Present New Research Related to ALKS 2680 at SLEEP 2025
PR NewswireAlkermes to Present New Research Related to ALKS 2680 at SLEEP 2025
PR NewswireAlkermes plc Reports First Quarter 2025 Financial Results
PR NewswireAlkermes plc Reports First Quarter 2025 Financial Results
PR NewswireNew Survey Provides Insights into Diagnosis and Treatment Journey for People Living With Alcohol Use Disorder (AUD)
PR NewswireNew Survey Provides Insights into Diagnosis and Treatment Journey for People Living With Alcohol Use Disorder (AUD)
PR NewswireAlkermes to Report First Quarter Financial Results on May 1, 2025
PR NewswireAlkermes to Report First Quarter Financial Results on May 1, 2025
PR NewswireAlkermes to Participate in the 24th Annual Needham Virtual Healthcare Conference
PR NewswireAlkermes to Participate in the 24th Annual Needham Virtual Healthcare Conference
PR NewswireAlkermes Announces Initiation of Vibrance-3 Phase 2 Study Evaluating ALKS 2680 for the Treatment of Idiopathic Hypersomnia
PR NewswireAlkermes Announces Initiation of Vibrance-3 Phase 2 Study Evaluating ALKS 2680 for the Treatment of Idiopathic Hypersomnia
PR NewswireNew National Survey of Healthcare Providers Offers Insights Into the Dynamic and Challenging Treatment Journey for People Living With Schizophrenia or Bipolar I Disorder
PR NewswireNew National Survey of Healthcare Providers Offers Insights Into the Dynamic and Challenging Treatment Journey for People Living With Schizophrenia or Bipolar I Disorder
PR NewswireAlkermes to Participate in Upcoming Investor Conferences
PR NewswireAlkermes to Participate in Upcoming Investor Conferences
PR NewswireAlkermes plc Reports Financial Results for the Fourth Quarter and Year Ended Dec. 31, 2024 and Provides Financial Expectations for 2025
PR NewswireAlkermes plc Reports Financial Results for the Fourth Quarter and Year Ended Dec. 31, 2024 and Provides Financial Expectations for 2025
PR NewswireAlkermes to Report Fourth Quarter and Year-End Financial Results on Feb. 12, 2025
PR NewswireAlkermes to Report Fourth Quarter and Year-End Financial Results on Feb. 12, 2025
PR NewswireAlkermes to Present at the 43rd Annual J.P. Morgan Healthcare Conference
PR NewswireAlkermes to Present at the 43rd Annual J.P. Morgan Healthcare Conference
PR NewswireAlkermes to Participate in Upcoming Investor Conferences
PR NewswireAlkermes to Participate in Upcoming Investor Conferences
PR NewswireAlkermes to Participate in Two Upcoming Investor Conferences
PR NewswireAlkermes to Participate in Two Upcoming Investor Conferences
PR NewswireAlkermes Highlights Presentations From Across Neuroscience Portfolio at Key Fall 2024 Scientific Conferences
PR NewswireAlkermes Highlights Presentations From Across Neuroscience Portfolio at Key Fall 2024 Scientific Conferences
PR NewswireAlkermes plc Reports Third Quarter 2024 Financial Results
PR NewswireAlkermes plc Reports Third Quarter 2024 Financial Results
PR NewswireAlkermes to Report Third Quarter Financial Results on October 24, 2024
PR NewswireAlkermes to Report Third Quarter Financial Results on October 24, 2024
PR NewswireAlkermes to Host Investor Event to Review Orexin Portfolio Strategy
PR NewswireAlkermes to Host Investor Event to Review Orexin Portfolio Strategy
PR NewswireAlkermes to Present Positive Clinical Data From Phase 1b Study of ALKS 2680 in Patients With Narcolepsy Type 2 and Idiopathic Hypersomnia at Sleep Europe 2024
PR NewswireAlkermes to Participate in the TD Cowen 4th Annual Novel Mechanisms in Neuropsychiatry Conference
PR NewswireAlkermes Announces Launch of 7th Annual Alkermes Pathways Research Awards® Program
PR NewswireAlkermes Announces Launch of 7th Annual Alkermes Pathways Research Awards® Program
PR NewswireAlkermes to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
PR NewswireAlkermes to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
Wer­bung

Alkermes News

Alkermes News: auf dieser Seite finden Sie alle Alkermes News und Nachrichten zur Alkermes Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Alkermes News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Alkermes News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.